Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering ...

ImmunoPrecise Antibodies Ltd., an AI-powered antibody company, has partnered with RIBOPRO, a technology provider specializing ...

Scientists have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman ...

New research from the Perelman School of Medicine at the University of Pennsylvania suggests that a combination of messenger ...

ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody discovery and ...

The Trump administration has started quietly re-hiring some of the FDA employees that it fired last week in a process that ...

DUBLIN--(BUSINESS WIRE)--The "Lipid Nanoparticle Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Lipid Nanoparticle, Type of Molecule Delivered, Company Size ...

By adjusting the fat levels in mRNA-based drugs, researchers have found a way to bypass the liver and go straight to the ...

The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and ...